Glen Wakeman – Chief Executive Officer of LaunchPad Holdings, LLC

Glen Wakeman is the current founder and CEO of LaunchPad Holdings, LLC, an automated software as a service firm that enables start-up entrepreneurs to increase their rate of success by following a guided online business planning approach. In 1981, he completed his academic degree in Bachelor of Science in Economics and Finance from the University of Scranton. In 1993, Wakeman studied at the University of Chicago where he managed to graduate with a Master of Business Administration in Finance. Glen Wakeman is a writer, mentor, investor, entrepreneur, and an affluent global business executive. Additionally, he is also a person with a significant knowledge in risk management, governance, credit related matters, and retail and institutional banking.

Wakeman started his successful professional journey at GE Capital, a company that offers leases, commercial loans, and middle market finance solutions that can assist business persons to build a future that is better, and stronger (https://ideamensch.com/glen-wakeman/). At GE Capital, Glen Wakeman held various roles in business development, and in profit and loss. Later, Wakeman joined Doral Financial Corporation where he served as the company’s President and Chief Executive Officer. Glen has been employed in 32 countries and has resided in six. His profession at GE Capital, and as the Chairman of Doral Financial Corporation which spans for two decades has led to a significant transformation of the businesses. The organizations have acquired $15bn in assets, and have employed more than 17,000 workers. He was also the Board Chairman of Doral Bank. Moreover, Glen Wakeman has also founded and taken authority over GE and Nova Four (BusinessWire). At GE and Nova Four, Wakeman was recognized by the Board of Directors as a role model in Growth Leadership.

Glen Wakeman blogs frequently about global affairs, business transformation, leadership and emerging markets. He also gives entrepreneurs advice on angel financing, marketing strategy, and capital raising. Among the few business startups that Glen has advised and mentored include Dreamfunded, and Sitter Bees. He has also served as a consultant to several C-level executives. Wakeman is enthusiastic about innovation, exponential growth, mergers and acquisitions, divestitures, and executive development of entrepreneurs who are starting up new businesses.

Amicus Therapeutics Operations and History

Amicus Therapeutics is an American firm based in Cranbury, New Jersey. It is one of the major bio-pharmaceutical companies and is renowned in America. It was declared public in the year 2007 under the symbol of trade FOLD. This was after the previous symbol AMTX suggestion which was withdrawn in the year 2006. Well, a known number of venture capital companies funded Amicus such as Canaan Partners, New Enterprise Associates, and Radius Ventures.

 

Their main focus is on rare and orphan health conditions specifically those termed as lysosomal storage disorders. The firm’s product improvement is highly concentrated in the CHART® (Chaperone-Advanced Replacement Therapy). This portfolio has its main interests in the improvement of therapies dealing with the replacement of enzymes. In the year 2014, Amicus was listed as the largest platform working on small molecule pharmacological chaperones in the field of pharmaceuticals (https://seekingalpha.com/article/4073303-amicus-therapeutics-small-biotech-seems-big-mo).

 

Amicus Therapeutics does not have an ability of its own in manufacturing, so it relies on contract manufacturing instead. In the year 2008, the firm made wide its single premises based in New Jersey to a second location based in San Diego. Before 2010, the firm started facing a great financial problem causing a major halt of a multi-years collaboration agreeing with Shire. During the time of halt, the financial procedures were executed primarily and were made through a private placing of convertible stock.

 

In the year 2010, the firm received a total amount of 500,000 dollars from The Michael J. Fox Foundation. These funds were to help him go on supporting studies that took place in David Geffen School of Medicine based at UCLA. The company later received 210,300 dollars from the Alzheimer’s Drug Discovery Foundation. The grants enabled Amicus Therapeutics to support Icahn School of Medicine based at Mount Sinai. All this was conducted through the Alzheimer’s disease Research Center to help tasks related to pre-clinical works.

 

In 2013, Amicus Therapeutics challenged Callidus Biopharma, which became their competitor in the treatment of enzyme replacement therapy for Pompe disease. In 2015, Amicus then acquired scioderm; a rare disease firm focused on the development of treatment for Epidermolysis Bullosa, EB for up to a total of 947 million dollars in both stock and cash. To date, Amicus Therapeutics has made available treatment affordable to EB patients.

Gama

Alexandre Gama is a Brazilian entrepreneur and creative professional whose main focus is within the advertising and communications industry. He began his career after receiving his degree in advertising and communications from Armando Alvares Penteado Foundation. His first job in the field was as a writer for Standard Ogilvy & Mather, where he began working in 1982. He worked for several different advertising agencies over the years, and in 1999 he left his job and started his own company: Neogama. Neogama was an astounding success. In the first year of business at Neogama, the company was awarded a Lion in the Cannes Festival. No company had managed to do so before it. For the company’s first three years, Neogama was the quickest growing agency in Brazil. Gama has won many awards and has taken an interest in his country’s music scene. Alongside his work in the advertising world, he also fosters the success of many up and coming Brazilian acoustic guitar players.

Success Academy Introduces Educational Institute

Eva Moskowitz, the CEO and founder of Success Academy stated that she had two main goals when she started the largest charter school in NYC about 10 years ago. She wanted to open a school that was high-performing and wanted to improve the American education system.

 

Moskowitz confirmed that there are no plans to expand Success Academy outside of the New York area right now, but the school’s online platform has been put in place to expand the network of Success Academy beyond the largest school district in the United States.

 

Recently, Moskowitz and her colleagues unveiled the Success Academy Education Institute from their Lower Manhattan headquarters. The online portal is available free of charge and provides access to strategies for teacher and curriculum development for the 41 educators that are employed by Success Academy’s 41 schools in the NYC area.

 

Moskowitz, a former Democratic NYC councilwoman, states that there are too many children across the U.S. who are “trapped” in educational institutions where they aren’t learning to write, read or comprehend mathematics and science. She says that she and the Success Academy staff feel compelled to be part of the solution. Moskowitz also asserts that the goal of the Ed Institute is to share information and resources with teachers around the United States and the world.

 

The accomplishments of Success Academy were also celebrated recently. The school is responsible for improving the academic performance of low-income minority students earned Success Academy the $250,000 Broad Prize. The money is designated for college readiness programs, including campus visits and scholarships.

 

The latest efforts of Success Academy speaks to the heart of the charter school’s mission and principles, which were founded over 25 years ago: to approach education in a new way, and to share those lessons, results and challenges with the education community.

 

Success Academy’s online platform, which offers a literacy curriculum for kindergarten through fourth grade, is the initial step in an overall effort to expose teachers around the nation to Success Academy’s mantra. This fall, the school plans to open a training facility for teachers in Manhattan’s Hudson Yards, complete with a lab school for students in kindergarten through eighth grade.

Success Academy named finalist for prestigious national charter school award

https://www.facebook.com/SuccessAcademies/

Litigatior Karl Heideck and the Litigation Process

     A litigator, or trial lawyer, is an attorney who manages plaintiffs and defendants in civil court matters. They are unique as they handle every phase of the litigation process. There are 7 parts to the litigation process: investigation, pleadings, discovery, pre-trial, trial, settlement, and appeals. The day to day activities can vary depending on whether the litigator works in a small or large firm, however you typically start out at the bottom and work your way up. This means you spend a lot of time doing research and a lot of writing notes or memos. Litigators often start out simply observing or they may get to argue in small claims court to get experience. Litigation attorneys must have excellent written and oral skills, a Bachelor’s and Law Degree, and pass the state bar exam.

In the investigation phase, litigators find and talk to witnesses, gather evidence, and see if there is enough evidence to file a suit. The pleading portion means that the attorney will file a motion to dismiss or amend a charge. The discovery process is simple exchanging information between the involved parties. Pre-trial is gathering everything for trial and trial is arguing you case in front of a judge and jury. Settlement is the payoff to the client and appeal is filing a motion to have another trial.

Karl Heideck is a litigation attorney who practices in Philadelphia. He graduated from Temple University in early 2009, as well as James E. Beasley School of Law. Karl Heideck currently works for Grant and Eisenhofer as a contract attorney and has worked there since 2015. He has previously worked for Pepper Hamilton, LLC, as well as Conrad O’Brien. Karl Heideck has special skills in the areas of legal writing, corporate law, product liability, and many more. Karl Heideck brings many years of experience and a wide array of tools to the table that make him a valuable litigation attorney.

Find more at https://members.nationalgeographic.com/804161697022/.